Pulmonary vascular disease

A. Peacock (Glasgow, United Kingdom)

Source: HERMES Summer School 2014 - Educational material
Number: 8
Disease area: Pulmonary vascular diseases

PDF journal article, handout or slides

Rating: 4.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Peacock (Glasgow, United Kingdom). Pulmonary vascular disease. HERMES Summer School 2014 - Educational material

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary vascular diseases
Source: ERS Skills Course 2016
Year: 2016

Pulmonary vascular diseases
Source: ERS Course 2015
Year: 2015

COVID-19 and the pulmonary circulation
Source: ERS webinar 2020: COVID-19 and the pulmonary circulation
Year: 2020


Pulmonary hypertension and pulmonary vascular disease: course report
Source: Breathe, 14 (1) e4; 10.1183/20734735.019917
Year: 2018



Smooth muscle microparticles as novel biomarkers of vascular remodelling and inflammation in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Pulmonary vascular remodelling in pulmonary disease
Source: Annual Congress 2011 - The burden of pulmonary hypertension in respiratory disease
Year: 2011


Updates in pulmonary hypertension and other pulmonary vascular diseases
Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019
Year: 2019



Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017

Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Pulmonary vascular reactivity in pulmonary hypertension due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013

Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary vascular and cardiac impairment in interstitial lung disease
Source: Eur Respir Rev 2017; 26: 160128
Year: 2017



Non-invasive haemodynamic measurement to detect treatment response in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014